Bifogade filer
Kurs & Likviditet
Prenumeration
Du har en aktiv prenumeration.
Prenumerera på pressmeddelanden från Ziccum via email.
Du prenumererar på följande språk.
Välj vilka språk du vill prenumerera på.
Modular Finance AB kommer att hantera vissa av dina personuppgifter om du väljer att prenumerera. Mer information om vår personuppgiftshantering finns här.
Beskrivning
Land | Sverige |
---|---|
Lista | First North Stockholm |
Sektor | Hälsovård |
Industri | Läkemedel & Handel |
2024-09-05 10:00:00
Watch Ziccum CEO Ann Gidner in a comprehensive interview in Swedish with analyst Jonathan Furelid on the highlights of Ziccum’s Q2 2024 report and the company’s current and coming status.
CEO Ann Gidner provides investors with updates and insights on further mRNA/LNP milestones, including the recently disclosed significant mRNA activity increase with LaminarPace, the status of Ziccum’s current partner projects including the newly signed ReCode Therapeutics deal, the growing industry-wide interest for Ziccum and the progress in solidifying Ziccum’s intellectual property protection.
You may watch the interview here: https://youtu.be/6ttsdxZh6UM